Coca-Cola HBC AG (OTC: CCHGY) reported a decline in its net profit for the fourth quarter.
Coca-Cola HBC's quarterly comparable net profit dropped 11.4% to 30.4 million euros ($34.6 million) from 34.3 million euros.
Sales volume gained 0.8%...
Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced
the first presentation of positive safety and efficacy data from the
AUX-CC-867 MULTICORD (MULtiple Treatment Investigation of...
By Andy Batts:
BioSpecifics Technologies (NASDAQ:BSTC) recently announced positive, statistically significant results from a randomized, double-blind Phase 2a study of collagenase clostridium histolyticum or CCH (known as XIAFLEX in the in the US...
WASHINGTON (dpa-AFX) - Auxilium Pharmaceuticals, Inc. (AUXL), a specialty
biopharmaceutical company, announced positive results from a randomized,
double-blind Phase 2a trial of collagenase clostridium histolyticum or CCH for
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Coca-Cola Hellenic Bottling Company (CCH):